Ergomed PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Rolf Soderstrom, was filed 14 Feb 2020.
Ergomed PLC: what insiders have been doing
Ergomed PLC is a listed company. Its directors and officers file their transactions with RNS (LSE). The past year has been quiet: not a single insider filing for Ergomed PLC. The previous disclosure was published on 14 February 2020.
Looking back to 2017, when coverage begins, insiders filed 8 purchases and no sales.
For comparison within the same market, see the insider buying recorded at CMC Markets plc. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
- 5,000 shares@ £4.56100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20200214070005_3494639_20200331164941622_13289-0Canonical exit: 11 May 2020 (T+90)
- 5,000 shares@ £4.56100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20200214070005_3494639_20200331164941622_13289-1Canonical exit: 11 May 2020 (T+90)
- 10,000 shares@ £4.56100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20200214070005_3494639_20200331164941622_13289-2Canonical exit: 11 May 2020 (T+90)
- 10,000 shares@ £4.56100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20200214070005_3494639_20200331164941622_13289-3Canonical exit: 11 May 2020 (T+90)
- 10,910 shares@ £4.56100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20200214070005_3494639_20200331164941622_13289-4Canonical exit: 12 May 2020 (T+90)
- 100,000 shares@ £0.01Outside of a trading venueISIN GB00BN7ZCY67FCA-NSM:LSE20190724080434_14161022_20200326185123419_10675
- 200,000 shares@ £3.03London Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20190625070014_14122712_20200326185128634_7413Canonical exit: 22 Sept 2019 (T+90)
- 64,000 shares@ £2.70100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20190613070015_14109062_20200326185129719_20866Canonical exit: 10 Sept 2019 (T+90)
- 100,000 shares@ £1.90100.0% of flowLondon Stock Exchange, AIMISIN GB00BN7ZCY67FCA-NSM:LSE20170404105001_13182939_20200330131458109_2267Canonical exit: 2 Jul 2017 (T+90)
9 of 9 declarations
About Ergomed PLC
Ergomed PLC is a company specializing in drug development services and clinical research. It provides solutions to pharmaceutical and biopharmaceutical companies.
